EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Development and validation of a multimodal risk prediction model for early COPD progression: a retrospective study integrating clinical, functional, and CT radiomic features

Jia Zhang, Qin Yang, Shuangme Dai, Jiaxin Li, Zhe Zhang, Zihan Jia, Weihua Zhu, Rui Yang, Xuelian Bai, Wenya Li, Xin Zhang, Xinjun Zhang und 2 weitere

Therapeutic Advances in Respiratory Disease · 2026-07 · 20

DOI: 10.1177/17534666261466906 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 13.07.2026. Verfasst von Jia Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Aerospace Center Hospital, Beijing, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Tomography, X-Ray Computed, Lung. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early identification of rapid progression in patients with preserved ratio but chronic cough remains challenging.

Objective

To develop and validate an integrated multimodal prediction model that combines clinical phenotypes, small airway function indices, and chest CT quantitative features for stratifying progression risk in individuals with preserved ratio, chronic cough, and early COPD features.

Design

Retrospective cohort study with external validation.

Methods

In this retrospective cohort study of 408 participants with chronic cough (⩾3 months) and preserved spirometry (FEV 1 /FVC ⩾ 0.7), we integrated clinical profiles, pulmonary function (including small airway indices), and AI-quantified chest CT quantitative features. A three-stage modeling approach was used: variable screening with generalized estimating equations, predictor selection via LASSO regression, and construction of a Random Survival Forest–Cox hybrid model to predict a composite outcome of accelerated lung function decline (annual FEV 1 decline >40 mL) or acute exacerbation. External validation was performed using an independent cohort (COPDGene, n = 312, 82 outcome events), with 3-year follow-up for prediction. The model underwent internal validation (10-fold cross-validation), with interpretability assessed via SHapley Additive exPlanations (SHAP).

Results

Multivariable analysis confirmed small airway dysfunction and mucus plug burden as independent predictors of accelerated FEV 1 decline (all p < 0.001), with a significant synergistic interaction (β = 2.34, p = 0.003). The final nine-feature model showed excellent discrimination, with a time-dependent AUC of 0.872 (95% CI: 0.843–0.901) on internal validation and 0.843 (95% CI: 0.812–0.874) on external validation. SHAP analysis identified small airway parameters and mucus plug burden as the top contributors, jointly accounting for 68.4% of predictive output. A nomogram and online calculator were developed for clinical use.

Conclusion

We developed and validated a robust multimodal prediction model that accurately stratifies progression risk in individuals with preserved ratio, chronic cough, and early COPD features. This tool facilitates personalized risk assessment and holds promise for guiding precision management strategies to improve outcomes in this high-risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveTomography, X-Ray ComputedLungHumansRetrospective StudiesDisease ProgressionFemaleMaleRisk AssessmentPredictive Value of TestsMiddle AgedAgedRadiomicsChronic CoughReproducibility of ResultsForced Expiratory VolumeRisk FactorsSpirometryTime Factors

Stichwörter der Autor:innen

chronic obstructive pulmonary diseaseearly diagnosismucus plugspreserved ratio impaired spirometryquantitative CTrisk predictionsmall airway dysfunction

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Aerospace Center Hospital, Beijing, China.
  • Department of Pulmonary and Critical Care Medicine, Aerospace Center Hospital, No. 15 Yuquan Road, Haidian District, Beijing 100049, China.

ORCID-Profile: Wailong Zou

Zitieren

APA

Zhang, J., Yang, Q., Dai, S., Li, J., Zhang, Z., Jia, Z., Zhu, W., Yang, R., Bai, X., Li, W., Zhang, X., Zhang, X., Chen, J., & Zou, W. (2026). Development and validation of a multimodal risk prediction model for early COPD progression: a retrospective study integrating clinical, functional, and CT radiomic features. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261466906

Vancouver

Zhang J, Yang Q, Dai S, Li J, Zhang Z, Jia Z, et al. Development and validation of a multimodal risk prediction model for early COPD progression: a retrospective study integrating clinical, functional, and CT radiomic features. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261466906

BibTeX
@article{Zhang2026,
  author = {Zhang, Jia and Yang, Qin and Dai, Shuangme and Li, Jiaxin and Zhang, Zhe and Jia, Zihan and Zhu, Weihua and Yang, Rui and Bai, Xuelian and Li, Wenya and Zhang, Xin and Zhang, Xinjun and Chen, Jichao and Zou, Wailong},
  title = {Development and validation of a multimodal risk prediction model for early COPD progression: a retrospective study integrating clinical, functional, and CT radiomic features},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2026},
  volume = {20},
  doi = {10.1177/17534666261466906}
}
Kostenlos starten →